Cardax, Inc. (CDXI)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Jun 13, 2025
Cardax Market Cap
Cardax has a market cap or net worth of $83.00 as of August 12, 2025. Its market cap has decreased by -100.00% in one year.
Market Cap
83.00
Enterprise Value
n/a
Revenue
500.71K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since February 10, 2014, Cardax's market cap has decreased from 191.71M to 83.00, a decrease of -100.00%. That is a compound annual growth rate of -72.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 13, 2025 | 83.00 | - |
| Dec 31, 2024 | 83.00 | -49.70% |
| Dec 27, 2022 | 165.00 | -99.96% |
| Dec 30, 2021 | 412.79K | -68.27% |
| Dec 31, 2020 | 1.30M | -81.33% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.72M |
| Veradigm | 789.71M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 610.23M |
| Glass House Brands | 561.16M |
| American Oncology Network | 385.65M |
| Northwest Biotherapeutics | 360.45M |
| CytoDyn | 300.75M |